Predictors of Lifestyle Intervention Attrition or Weight Loss Success in Women with Polycystic Ovary Syndrome Who Are Overweight or Obese

被引:48
|
作者
Moran, Lisa J. [1 ,2 ]
Noakes, Manny [3 ]
Clifton, Peter [4 ]
Buckley, Jon [4 ]
Brinkworth, Grant [3 ]
Thomson, Rebecca [4 ]
Norman, Robert J. [1 ,5 ]
机构
[1] Univ Adelaide, Robinson Res Inst, Sch Med, Adelaide, SA 5000, Australia
[2] Monash Univ, Monash Ctr Hlth Res & Implementat, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3163, Australia
[3] CSIRO, Div Hlth Sci & Nutr, Clayton, Vic, Australia
[4] Univ South Australia, ARENA, Sansom Inst Hlth Res, Adelaide, SA 5000, Australia
[5] Fertil SA, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
weight loss; attrition; polycystic ovary syndrome; diet; exercise; lifestyle; DIETARY-COMPOSITION; INSULIN-RESISTANCE; BODY-COMPOSITION; DEPRESSION; MANAGEMENT; EXPECTATIONS; IMPROVEMENT; ADHERENCE; PROGRAM; GLUCOSE;
D O I
10.3390/nu11030492
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background/objectives: Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women. Weight management is a first-line treatment for PCOS according to international evidence-based guidelines. However, the factors associated with attrition or success in weight loss interventions are not known for women with PCOS. The objective of this study was to identify characteristics associated with attrition and weight loss success in women with PCOS and overweight or obesity undergoing weight loss interventions. Methods: Four randomised controlled clinical weight loss trials comprising energy restricted diets and/or exercise interventions of 2-8 months duration. The interventions were conducted over 2001-2007 in outpatient clinical research centres with n = 221 premenopausal women with PCOS and overweight/obesity recruited through community advertisement. The main outcome measures were attrition and >= 5% weight loss at 2 months and study completion. Results: Weight loss was 5.7 +/- 2.9 kg at 2 months and 7.4 +/- 5.3 kg after study completion (p < 0.001). Attrition was 47.1% and >= 5% weight loss occurred in 62.5% and 62.7% of women at 2 months and study completion respectively. Baseline depressive symptoms (OR 1.07 95% CI 0.88, 0.96, p = 0.032) and lower appointment attendance by 2 months (OR 0.92 95% CI 0.88, 0.96, p < 0.001) were independently associated with attrition. Lower appointment attendance over the whole study was independently associated with not achieving >= 5% weight loss at study completion (OR 0.95 95% CI 0.92, 0.99, p = 0.020). Conclusions: Despite high attrition, successful weight loss was achieved by 63% of women with PCOS in a clinical research setting. Higher baseline depressive symptoms were associated with greater attrition and higher appointment attendance was associated with lower attrition and greater weight loss success. These finding have implications for development of successful weight management programs in PCOS.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Altered cardiorespiratory response to exercise in overweight and obese women with polycystic ovary syndrome
    Rissanen, Antti-Pekka E.
    Koskela-Koivisto, Tiina
    Hagglund, Harriet
    Koponen, Anne S.
    Aho, Jyrki M.
    Poyhonen-Alho, Maritta
    Tiitinen, Aila
    Tikkanen, Heikki O.
    Peltonen, Juha E.
    [J]. PHYSIOLOGICAL REPORTS, 2016, 4 (04):
  • [42] Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome
    Brinkworth, G. D.
    Noakes, M.
    Moran, L. J.
    Norman, R. J.
    Clifton, P. M.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (11) : 1308 - 1314
  • [43] Body iron stores are increased in overweight and obese women with polycystic ovary syndrome
    Escobar-Morreale, HF
    Luque-Ramírez, M
    Alvarez-Blasco, F
    Botella-Carretero, JI
    Sancho, J
    San Millán, JL
    [J]. DIABETES CARE, 2005, 28 (08) : 2042 - 2044
  • [44] Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome
    Ujvari, D.
    Hulchiy, M.
    Calaby, A.
    Nybacka, A.
    Bystrom, B.
    Hirschberg, A. L.
    [J]. HUMAN REPRODUCTION, 2014, 29 (07) : 1526 - 1535
  • [45] Insulin resistance and adverse metabolic profile in overweight/obese and normal weight of young women with polycystic ovary syndrome
    Gholinezhad, Maryam
    Gholsorkhtabaramiri, Masoumeh
    Esmaeilzadeh, Sedigheh
    Ghanbarpour, Azita
    [J]. CASPIAN JOURNAL OF INTERNAL MEDICINE, 2018, 9 (03) : 260 - 267
  • [46] The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome
    Panidis, Dimitrios
    Tziomalos, Konstantinos
    Papadakis, Efstathios
    Chatzis, Panagiotis
    Kandaraki, Eleni A.
    Tsourdi, Elena A.
    Katsikis, Ilias
    [J]. CLINICAL ENDOCRINOLOGY, 2014, 80 (03) : 432 - 438
  • [47] A two purpose use of Orlistat in obese women with polycystic ovary syndrome: weight loss and androgen reduction
    Salehpour, Saghar
    Veisi, Pegah
    Saharkhiz, Nasrin
    Hoseini, Sedigheh
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 131 - 131
  • [48] Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome
    Marzouk, Tayseer M.
    Ahmed, Waleed A. Sayed
    [J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2015, 28 (06) : 457 - 461
  • [49] Lifestyle changes in women with polycystic ovary syndrome
    Moran, Lisa J.
    Hutchison, Samantha K.
    Norman, Robert J.
    Teede, Helena J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (07):
  • [50] Lifestyle changes in women with polycystic ovary syndrome
    Moran, Lisa J.
    Hutchison, Samantha K.
    Norman, Robert J.
    Teede, Helena J.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (02):